Aemetis Inc

Aemetis Inc(AMTX)股票分析

$1.370

-0.084 (-6.16%)收盤時

Loading chart…
最高
1.485
開盤
1.460
成交量加權均價
1.41
成交量
543.06K
市值
134.08M
最低
1.360
成交金額
763.02K
企業價值/稅息折舊攤銷前利潤(TTM)
11.76

Aemetis, Inc. is a renewable natural gas and renewable fuels company. The Company focused on the operation, acquisition, development and commercialization of technologies that lower fuel costs and reduce emissions. The Company’s segments include California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The California Ethanol segment consists of an approximately 65 million gallons per year ethanol plant in Keyes, California. The California Dairy Renewable Natural Gas segment is engaged in the production and sale of renewable natural gas and associated environmental attributes, consisting of anaerobic digesters located at diaries, a 36-mile biogas collection pipeline, and a biogas upgrading hub and pipeline interconnect that produces Renewable Natural Gas from the biogas. The India Biodiesel segment includes a biodiesel production plant in Kakinada, India with a production capacity of over 80 million gallons per year and administrative offices in Hyderabad, India.

AI 分析 of Aemetis Inc (AMTX)

賣出

Aemetis Inc (AMTX) is not a good buy right now. The current price is $1.46, and the RSI is at a very low 20.68, indicating oversold conditions. However, the company's financials show significant losses, with a net income of -$21.71 million in Q1 2026 and a gross margin of only 5.05%. Additionally, the stock has dropped 50.84% over the past year, reflecting ongoing struggles. The main risk is the forward P/E of 58.82, suggesting that investors are expecting substantial future growth that may not materialize given the current financial performance.

分析師評級(1)

上檔空間 +1359.85%
持有
0 買進
1 持有
0 賣出
目前: 1.37
最低
20.00
平均
20.00
最高
20.00

Ascendiant

2025-06-06

目標價

$20

買進

UBS

2025-05-09

目標價

—

買進

Ascendiant Capital

2025-03-17

目標價

$19

強烈買進

HC Wainwright & Co.

2025-03-14

目標價

$28

強烈買進

HC Wainwright & Co.

2024-12-23

目標價

$28

強烈買進

估值指標

Aemetis Inc(AMTX)目前預期本益比為 58.82,5 年平均預期本益比為 4.29。

預期本益比

嚴重高估
5 年均值 P/E
4.29
目前P/E
58.82
高估
25.86
低估
-17.28

預期 EV/EBITDA

合理
5 年均值 EV/EBITDA
63.31
目前EV/EBITDA
11.76
高估
342.59
低估
-215.98

預期股價營收比

合理
5 年均值 P/S
0.60
目前P/S
0.28
高估
1.11
低估
0.09

Alphio AI 對 AMTX 的價格情境

情境價格取自當年最後一個月度預測區間。機率為固定的模型權重(25 / 50 / 25),不構成保證。

樂

樂觀

樂觀 · 25%AMTX

$1.94

情境價格

基

基準

基準 · 50%AMTX

$1.60

情境價格

悲

悲觀

悲觀 · 25%AMTX

$1.00

情境價格

事件時間軸

2026-08-06 (ET)

09:30:00

Aemetis Q2 Revenue at $62.7M, Below Expectations

2026-05-07 (ET)

09:20:00

Aemetis Reports Q1 Revenue of $54.62M

2026-03-12 (ET)

08:10:00

Aemetis Q4 Revenue $43.307M, Below Consensus

2026-02-03 (ET)

08:30:00

Aemetis Subsidiary Secures $24M Biodiesel Orders

2025-12-30 (ET)

08:10:00

Aemetis Secures $17M in Federal Clean Energy Tax Credits

資訊

AMTX 常見問題 —— 由 Alphio AI 解答

Aemetis, Inc. is a renewable natural gas and renewable fuels company. The Company focused on the operation, acquisition, development and commercialization of technologies that lower fuel costs and reduce emissions. The Company’s segments include California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The California Ethanol segment consists of an approximately 65 million gallons per year ethanol plant in Keyes, California. The California Dairy Renewable Natural Gas segment is engaged in the production and sale of renewable natural gas and associated environmental attributes, consisting of anaerobic digesters located at diaries, a 36-mile biogas collection pipeline, and a biogas upgrading hub and pipeline interconnect that produces Renewable Natural Gas from the biogas. The India Biodiesel segment includes a biodiesel production plant in Kakinada, India with a production capacity of over 80 million gallons per year and administrative offices in Hyderabad, India. It operates in the Energy sector (INDUSTRIAL ORGANIC CHEMICALS industry).

Aemetis Inc (AMTX) is not a good buy right now. The current price is $1.46, and the RSI is at a very low 20.68, indicating oversold conditions. However, the company's financials show significant losses, with a net income of -$21.71 million in Q1 2026 and a gross margin of only 5.05%. Additionally, the stock has dropped 50.84% over the past year, reflecting ongoing struggles. The main risk is the forward P/E of 58.82, suggesting that investors are expecting substantial future growth that may not materialize given the current financial performance.

1 analysts cover AMTX: 0 rate it Buy, 1 Hold and 0 Sell. The average price target is 20.00.

暫無貼文

註冊或登入後參與討論

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

開始交易